NCT05756764Active, not recruiting
Anti-obesity Pharmacotherapy and Inflammation
Pilot Study of the Effect of Weight Loss by Pharmacotherapy on Chronic Pro-tumor Inflammatory Cells
Source: ClinicalTrials.gov · Last updated 9 Sept 2025
Brief summary (registry, in English)
This study evaluates the relationship between weight loss, circulating inflammatory markers and lipids from 24 patients before and after 6 months of pharmacotherapy as a standard of care for anti-obesity treatment
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 30 (estimated)
- First submitted
- 23 Feb 2023
- Start date
- 1 Jun 2023
- Primary completion date
- 30 Jan 2026
- Lead sponsor
- Louisiana State University Health Sciences Center in New Orleans
- Diseases
- Obesity
- NCT number
- NCT05756764
What you commit to
- Study type: Observational
- Planned participants: 30
- From 1 Jun 2023 to the primary completion date, 30 Jan 2026
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Taking medications with anti-inflammatory properties like glucocorticoids, prednisone, or non-steroidal anti-inflammatory medications, such as aspirin or Motrin Subjects on medications for long-term weight management such as phentermine-topiramate (Qsymia), orlistat (Xenical), naltrexone-bupropion (Contrave), and the glucagon-like peptide-1 receptor agonists such as liraglutide (Saxenda), and semaglutide (Wegovy).
Other illness
- Prior history of cancer
- Having any clinical symptoms of systemic inflammation, acute infections such as Coronavirus disease 2019, or chronic diseases such as cancer, tuberculosis, autoimmune disease, and AIDS
Other
- An adult unable to consent
- Prisoner
- Pregnancy or breastfeeding women
Who the study is looking for
- Body mass index (BMI): over 30 kg/m2
- Age: 35 to 60 years old
Age in the registry: 35 years to 60 years · Sex: All
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| LSU Clinical & Translational Research Center (CTRC - - LSUHSC-NO Coordinator of this site? Confirm its status | New Orleans | United States | Unknown status |
| Ochsner Health System - Biospecimen Coordinator of this site? Confirm its status | New Orleans | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.